|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Surgery, University of Virginia, Charlottesville, Virginia, United States
2 Pediatrics, University of Virginia, Charlottesville, Virginia, United States
3 Cardiovascular Research Center, University of Virginia, Charlottesville, Virginia, United States
* To whom correspondence should be addressed. E-mail: mz2v{at}virginia.edu.
Lung ischemia-reperfusion (IR) injury is a biphasic inflammatory process. Previous studies indicate that the later phase is neutrophil-dependent and that alveolar macrophages (AMs) likely contribute to the acute phase of lung IR injury. However, the mechanism is unclear. AMs become activated and produce various cytokines and chemokines in many inflammatory responses including transplantation. We hypothesize that AMs respond to IR by producing key cytokines and chemokines and that depletion of AMs would reduce cytokine/chemokine expression and lung injury after IR. To test this, using a buffer-perfused, isolated mouse lung model, we studied the impact of AM depletion by lipsome-clodronate on IR-induced lung dysfunction/injury and expression of cytokines/chemokines. IR caused a significant increase in pulmonary artery pressure, wet/dry weight ratio, vascular permeability and TNF-
, MCP-1 and MIP-2 expression as well as decreased pulmonary compliance, when compared to sham lungs. After AM depletion, the changes in each of these parameters between IR and sham groups were significantly attenuated. Thus AM depletion protects the lungs from IR-induced dysfunction and injury and significantly reduces cytokine/chemokine production. Protein expression of TNF-
and MCP-1 are positively correlated to IR-induced lung injury, and AMs are a major producer/initiator of TNF-
, MCP-1 and MIP-2. We conclude that AMs are an essential player in the initiation of acute lung IR injury.
This article has been cited by other articles:
![]() |
J. Chao, J. G. Wood, V. G. Blanco, and N. C. Gonzalez The Systemic Inflammation of Alveolar Hypoxia Is Initiated by Alveolar Macrophage-Borne Mediator(s) Am. J. Respir. Cell Mol. Biol., November 1, 2009; 41(5): 573 - 582. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Germano, P. Blyszczuk, A. Valaperti, G. Kania, S. Dirnhofer, U. Landmesser, T. F. Luscher, L. Hunziker, H. Zulewski, and U. Eriksson Prominin-1/CD133+ Lung Epithelial Progenitors Protect from Bleomycin-induced Pulmonary Fibrosis Am. J. Respir. Crit. Care Med., May 15, 2009; 179(10): 939 - 949. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. L. Lau, Y. Zhao, J. Kim, I. L. Kron, A. Sharma, Z. Yang, V. E. Laubach, J. Linden, G. Ailawadi, and D. J. Pinsky Enhanced fibrinolysis protects against lung ischemia-reperfusion injury. J. Thorac. Cardiovasc. Surg., May 1, 2009; 137(5): 1241 - 1248. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Yang, A. K. Sharma, J. Linden, I. L. Kron, and V. E. Laubach CD4+ T lymphocytes mediate acute pulmonary ischemia-reperfusion injury. J. Thorac. Cardiovasc. Surg., March 1, 2009; 137(3): 695 - 702. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Yang, A. K. Sharma, M. Marshall, I. L. Kron, and V. E. Laubach NADPH Oxidase in Bone Marrow-Derived Cells Mediates Pulmonary Ischemia-Reperfusion Injury Am. J. Respir. Cell Mol. Biol., March 1, 2009; 40(3): 375 - 381. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. M. Okamura, S. Pennathur, K. Pasichnyk, J. M. Lopez-Guisa, S. Collins, M. Febbraio, J. Heinecke, and A. A. Eddy CD36 Regulates Oxidative Stress and Inflammation in Hypercholesterolemic CKD J. Am. Soc. Nephrol., March 1, 2009; 20(3): 495 - 505. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. S. Farley, L. Wang, and S. Mehta Septic pulmonary microvascular endothelial cell injury: role of alveolar macrophage NADPH oxidase Am J Physiol Lung Cell Mol Physiol, March 1, 2009; 296(3): L480 - L488. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Kohmoto, A. Nakao, R. Sugimoto, Y. Wang, J. Zhan, H. Ueda, and K. R. McCurry Carbon monoxide-saturated preservation solution protects lung grafts from ischemia-reperfusion injury. J. Thorac. Cardiovasc. Surg., October 1, 2008; 136(4): 1067 - 1075. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Geudens, M. Van de Wouwer, B. M. Vanaudenaerde, R. Vos, C. Van De Wauwer, G. M. Verleden, E. Verbeken, T. Lerut, D. E. M. Van Raemdonck, and E. M. Conway The lectin-like domain of thrombomodulin protects against ischaemia-reperfusion lung injury Eur. Respir. J., October 1, 2008; 32(4): 862 - 870. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Eckle, L. Fullbier, A. Grenz, and H. K. Eltzschig Usefulness of pressure-controlled ventilation at high inspiratory pressures to induce acute lung injury in mice Am J Physiol Lung Cell Mol Physiol, October 1, 2008; 295(4): L718 - L724. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Qiu, L. Zheng, H. Gu, D. Chen, and Y. Chen Comparison between adult and infant lung injury in a rabbit ischemia-reperfusion model. J. Thorac. Cardiovasc. Surg., August 1, 2008; 136(2): 352 - 359. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. A. Bem, A. W. Farnand, V. Wong, A. Koski, M. E. Rosenfeld, N. van Rooijen, C. W. Frevert, T. R. Martin, and G. Matute-Bello Depletion of resident alveolar macrophages does not prevent Fas-mediated lung injury in mice Am J Physiol Lung Cell Mol Physiol, August 1, 2008; 295(2): L314 - L325. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. M. Gazoni, V. E. Laubach, D. P. Mulloy, A. Bellizzi, E. B. Unger, J. Linden, P. I. Ellman, T. C. Lisle, and I. L. Kron Additive protection against lung ischemia-reperfusion injury by adenosine A2A receptor activation before procurement and during reperfusion J. Thorac. Cardiovasc. Surg., January 1, 2008; 135(1): 156 - 165. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Forbes, M. Pickell, M. Foroughian, L.-J. Yao, J. Lewis, and R. Veldhuizen Alveolar macrophage depletion is associated with increased surfactant pool sizes in adult rats J Appl Physiol, August 1, 2007; 103(2): 637 - 645. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. M. Gazoni, C. G. Tribble, M. Q. Zhao, E. B. Unger, R. A. Farrar, P. I. Ellman, L. G. Fernandez, V. E. Laubach, and I. L. Kron Pulmonary Macrophage Inhibition and Inhaled Nitric Oxide Attenuate Lung Ischemia-Reperfusion Injury Ann. Thorac. Surg., July 1, 2007; 84(1): 247 - 253. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. K. Sharma, L. G. Fernandez, A. S. Awad, I. L. Kron, and V. E. Laubach Proinflammatory response of alveolar epithelial cells is enhanced by alveolar macrophage-produced TNF-{alpha} during pulmonary ischemia-reperfusion injury Am J Physiol Lung Cell Mol Physiol, July 1, 2007; 293(1): L105 - L113. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Fields, J. M. Bishai, W. Mitzner, and E. M. Wagner Effects of pulmonary ischemia on lung morphology Am J Physiol Lung Cell Mol Physiol, July 1, 2007; 293(1): L254 - L258. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Visit Other APS Journals Online |